Thomas Krogh
Director de Operaciones en VERITAS FARMS, INC. .
Cargos activos de Thomas Krogh
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VERITAS FARMS, INC. | Director de Operaciones | 25/08/2023 | - |
Corporate Officer/Principal | 01/01/2020 | 25/08/2023 |
Historial de carrera de Thomas Krogh
Antiguos cargos conocidos de Thomas Krogh.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CBR International Corp.
CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Corporate Officer/Principal | - | - |
Formación de Thomas Krogh.
University of Denver | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 2 |
Commercial Services | 2 |
Process Industries | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
VERITAS FARMS, INC. | Process Industries |
Empresas privadas | 1 |
---|---|
CBR International Corp.
CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Commercial Services |
- Bolsa de valores
- Insiders
- Thomas Krogh
- Experiencia